A detailed history of Nbc Securities, Inc. transactions in Ab Cellera Biologics Inc. stock. As of the latest transaction made, Nbc Securities, Inc. holds 11,420 shares of ABCL stock, worth $30,263. This represents 0.0% of its overall portfolio holdings.

Number of Shares
11,420
Previous 7,320 56.01%
Holding current value
$30,263
Previous $21,000 38.1%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 15, 2024

BUY
$2.39 - $3.49 $9,799 - $14,309
4,100 Added 56.01%
11,420 $29,000
Q2 2024

Jul 10, 2024

SELL
$2.73 - $4.73 $2,457 - $4,257
-900 Reduced 10.95%
7,320 $21,000
Q1 2024

Apr 05, 2024

BUY
$4.29 - $5.97 $2,145 - $2,985
500 Added 6.48%
8,220 $37,000
Q4 2023

Feb 07, 2024

BUY
$3.91 - $5.93 $3,910 - $5,930
1,000 Added 14.88%
7,720 $44,000
Q3 2023

Nov 03, 2023

BUY
$4.6 - $7.95 $30,911 - $53,424
6,720 New
6,720 $30,000

Others Institutions Holding ABCL

About AbCellera Biologics Inc.


  • Ticker ABCL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 285,139,008
  • Market Cap $756M
  • Description
  • AbCellera Biologics Inc. develops antibody discovery platform. Its full-stack, artificial intelligence-powered antibody discovery platform searches and analyzes the database of natural immune systems to find antibodies that could be developed as drugs. As of December 31, 2021, the company had 156 discovery programs that are either completed, in ...
More about ABCL
Track This Portfolio

Track Nbc Securities, Inc. Portfolio

Follow Nbc Securities, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nbc Securities, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Nbc Securities, Inc. with notifications on news.